CA1009550A - Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis) - Google Patents

Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis)

Info

Publication number
CA1009550A
CA1009550A CA185,183A CA185183A CA1009550A CA 1009550 A CA1009550 A CA 1009550A CA 185183 A CA185183 A CA 185183A CA 1009550 A CA1009550 A CA 1009550A
Authority
CA
Canada
Prior art keywords
mucoviscidosis
diagnosis
cystic fibrosis
diagnostic agent
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA185,183A
Other versions
CA185183S (en
Inventor
Ernst-Werner Busch
Walter Rittersdorf
Hans Lange
Hans-Georg Rey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732313744 external-priority patent/DE2313744C3/en
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of CA1009550A publication Critical patent/CA1009550A/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/382Cystic fibrosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA185,183A 1973-03-20 1973-11-06 Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis) Expired CA1009550A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732313744 DE2313744C3 (en) 1973-03-20 Procedure for the early diagnosis of cystic fibrosis

Publications (1)

Publication Number Publication Date
CA1009550A true CA1009550A (en) 1977-05-03

Family

ID=5875283

Family Applications (1)

Application Number Title Priority Date Filing Date
CA185,183A Expired CA1009550A (en) 1973-03-20 1973-11-06 Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis)

Country Status (1)

Country Link
CA (1) CA1009550A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013008239A1 (en) * 2011-07-14 2013-01-17 Mor Gideon Noninvasive detection of meconium in amniotic fluid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013008239A1 (en) * 2011-07-14 2013-01-17 Mor Gideon Noninvasive detection of meconium in amniotic fluid
US9144520B2 (en) 2011-07-14 2015-09-29 Gideon Mor Noninvasive detection of meconium in amniotic fluid

Also Published As

Publication number Publication date
DE2313744A1 (en) 1974-10-03
DE2313744B2 (en) 1975-02-20

Similar Documents

Publication Publication Date Title
CA985741A (en) Solid state universal battery monitor
CA1003313A (en) Thickened acid cleaner
AU463917B2 (en) Diagnostic agent
AU497109B2 (en) Agent for determining the coagulability of blood
CA980148A (en) Metal impact monitor
CA959389A (en) Diagnostic agent
CA998256A (en) Spirometer
CA1016049A (en) Aqueous cholesterol standard solution
CA1006091A (en) Antiinflammatory glycyrrhetinic acid compositions
IL46073A0 (en) Process for the activation of cholesterol oxidase and diagnostic agent for carrying out said process
AU504150B2 (en) Echographic examination
CA1009550A (en) Diagnostic agent for the diagnosis of mucoviscidosis (cystic fibrosis)
CA1028394A (en) Anaesthesia level monitor
CA1010844A (en) Process for the preparation of active carbon
CA1003330A (en) Diagnostic agent
AU497200B2 (en) Vehicle speed monitor
CA1010897A (en) Process for the preparation of 3-acetamido-5-amino-2,4,6-triiodobenzoic acid
CA1011729A (en) Derivatives of glycyrrhetinic acid
AU5841773A (en) Esters of b-(3, 4-dialkanoyloxyphenyl)-alanines
AU475111B2 (en) Diagnostic agents
CA991192A (en) Preparation process of benzamides 2,5-disubstituted
CA1007303A (en) Cardiac monitor
CA897387A (en) Universal folded plate shell structures
CA1026344A (en) Process for the preparation of oxadiazoline derivatives
CA1020358A (en) Dry blasting agents